Primary Research

 
Stock Quotes for Primary Research top ^
  • Industry: Utilities - Independent Power Producers
  • Sector: Utilities
  • Stock Style: Small Value
Sign-up for 8pen investment picks
  • Industry: Utilities - Independent Power Producers
  • Sector: Utilities
  • Stock Style: Small Value
  • Stock Type: Slow Growth
Sign-up for pri investment picks

 
Fund Quotes for Primary Research top ^
  • Holdings: Intel Corp , Royal Dutch Shell PLC ADR Class A , Encana Corp , Schlumberger NV , Apache Corporation ,
  • Category: Large Value
  • Morningstar Rating: 2 Stars
Sign-up for ptfdx investment picks
  • Holdings: Roche Holding AG , Samsung Electronics Co Ltd , Sanofi , Bayer AG , GlaxoSmithKline PLC ,
  • Category: Foreign Large Value
  • Morningstar Rating: 4 Stars
Sign-up for tfeqx investment picks
  • Holdings: Roche Holding AG , Samsung Electronics Co Ltd , Sanofi , Bayer AG , GlaxoSmithKline PLC ,
  • Category: Foreign Large Value
  • Morningstar Rating: 4 Stars
Sign-up for us8802105051 investment picks

 
News Articles for Primary Research top ^
OAK BROOK, IL , July 31, 2014 /PRNewswire/ - Primary Energy Recycling Corporation (TSX: PRI) (Primary Energy or the Company) today announced that its Board of Directors has declared a quarterly dividend on the common shares of the Company (the "Shares") in the amount of US$0.07 per Share.
Sign-up for Primary Energy Recycling announces quarterly dividend investment picks
2014/7/7
Primary Energy Recycling Announces Release Date for Second Quarter Results and Conference Call Canada NewsWire A digital conference call replay will be available until midnight on Thursday, August 21, 2014 (ET ) by calling (855) 859-2056 or (416) 849-0833.
Sign-up for Primary Energy Recycling Announces Release Date for Second Quarter Results and Conference Call investment picks
OAK BROOK, IL , July 7, 2014 /PRNewswire/ - Primary Energy Recycling Corporation (TSX: PRI) , a clean energy company that generates revenue from capturing and recycling recoverable heat and byproduct fuels from industrial processes, today announced that it will release its financial results for the second quarter ended June 30, 2014 , after market close on Wednesday, August 6, 2014 .
Sign-up for Primary Energy Recycling Announces Release Date for Second Quarter Results and Conference Call investment picks
Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and the Department of Environment and Primary Industries (DEPI) of the State of Victoria, announced today several significant steps the organizations are taking together to advance science for agriculture.
Sign-up for Dow AgroSciences, Victorian Department of Environment and Primary Industries Expand Relationship to Advance Science for Agriculture investment picks
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced the presentation of preclinical data demonstrating the promise of DCR-PH1, the Company’s therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1), a rare inherited liver disorder that often results in progressive and severe kidney damage.
Sign-up for Researchers Demonstrate Promise of Dicerna Investigational Therapy in Preclinical Model of Primary Hyperoxaluria Type 1 (PH1) investment picks
Cardinal Health to serve as primary supply chain partner for branded and generic pharmaceuticals under new multi-year agreement MEMPHIS, Tenn.
Sign-up for Fred's And Cardinal Health Announce Primary Supply Agreement investment picks
2014/8/6
In TO920 disseminated at 22:08e today, an error occurred in the "Financial Results" table.
Sign-up for /C O R R E C T I O N -- Primary Energy Recycling Corporation/ investment picks
2014/7/28
Pollard Banknote Named Primary Scratcher Ticket Supplier for the Virginia Lottery Canada NewsWire About Pollard Banknote Pollard Banknote is a leading lottery partner to more than 50 lotteries worldwide, providing high quality instant ticket products, licensed games and strategic marketing and management services for both traditional instant games and the emerging iLottery space of web, mobile and social channels.
Sign-up for Pollard Banknote Named Primary Scratcher Ticket Supplier for the Virginia Lottery investment picks
Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced that the United States Food and Drug Administration (FDA) approved Baxter’s subcutaneous treatment for adult patients with primary immunodeficiency (PI), HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. HYQVIA is the first subcutaneous immune globulin (IG) treatment approved for PI patients with a dosing regimen requiring only one infusion up to once per month (every three to four weeks) and one injection site per infusion to deliver a full therapeutic dose of IG.
Sign-up for FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency investment picks
2014/6/25
NEW YORK , June 25, 2014 /PRNewswire/ -- Morningstar Credit Ratings, LLC today affirmed its 'MOR CS1' commercial mortgage primary, master, and special servicer rankings for KeyBank, N.A. (KeyBank), a wholly owned bank subsidiary of KeyCorp.
Sign-up for Morningstar Credit Ratings, LLC Affirms 'MOR CS1' Commercial Mortgage Primary, Master, and Special Servicer Rankings for KeyBank, N.A. investment picks
Eighty Percent of Patients Treated with G-202 had No Tumor Growth at Two Months SAN ANTONIO , July 15, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the APPLE 2014 presentation.
Sign-up for GenSpera Presents G-202 HCC Clinical Trial Update at 5th Asia-Pacific Primary Liver Cancer Expert Meeting investment picks
Results Published Ahead of Print in the Journal of Acquired Immune Deficiency Syndromes (JAIDS) WALTHAM, Mass.
Sign-up for New Alere™ q Point-of-Care Early Infant Diagnosis Test Prototype Accurately Detects HIV in Infants with High Sensitivity and Specificity in Primary Health Clinics in Mozambique investment picks
Latest Data Sweep from a 285 Patient Subgroup Shows An Impressive 57% Improvement in Overall Survival Data Continues to Validate Phase III OPTIMA Study Design LAWRENCEVILLE, N.J. , July 28, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in combination with radiofrequency ablation (RFA) in primary liver cancer, also known as hepatocellular carcinoma (HCC). As of June 30, 2014 , the latest quarterly Overall Survival (OS) analysis demonstrated that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox® and optimized RFA provided a 57% improvement in OS compared to optimized RFA alone.
Sign-up for Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver Cancer investment picks
2014/7/22
NEW YORK , July 22, 2014 /PRNewswire/ -- Morningstar Credit Ratings, LLC today assigned its 'MOR CS2' commercial mortgage primary servicer and special servicer rankings for Cohen Financial Services (DE), LLC.
Sign-up for Morningstar Credit Ratings, LLC Assigns 'MOR CS2' Commercial Mortgage Primary Servicer and Special Servicer Rankings for Cohen Financial Services (DE), LLC investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Primary Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Primary Energy Recycling  |  Next: Prime Rate